Abstract
The effect of counterion was evaluated on the photodegradation behavior of six prazosin salts, viz., prazosin hydrochloride anhydrous, prazosin hydrochloride polyhydrate, prazosin tosylate anhydrous, prazosin tosylate monohydrate, prazosin oxalate dihydrate, and prazosin camsylate anhydrous. The salts were subjected to UV–Visible irradiation in a photostability test chamber for 10 days. The samples were analyzed for chemical changes by a specific stability-indicating high-performance liquid chromatography method. pH of the microenvironment was determined in 10% w/v aqueous slurry of the salts. The observed order of photostability was: prazosin hydrochloride anhydrous > prazosin camsylate anhydrous ∼ prazosin-free base > prazosin hydrochloride polyhydrate > prazosin tosylate anhydrous > prazosin oxalate dihydrate ∼ prazosin tosylate monohydrate. Multivariate analysis of the photodegradation behavior suggested predominant contribution of the state of hydration and also intrinsic photosensitivity of the counterion. Overall, hydrated salts showed higher photodegradation compared to their anhydrous counterparts. Within the anhydrous salts, aromatic and carbonyl counterion-containing salts showed higher susceptibility to light. The pH of microenvironment furthermore contributed to photodegradation of prazosin salts, especially for drug counterions with inherent higher pH. The study reveals importance of selection of a suitable drug salt form for photosensitive drugs during preformulation stage of drug development.
Similar content being viewed by others
REFERENCES
Berge S, Bighley L, Monkhouse D. Pharmaceutical salts. J Pharm Sci. 1977;66:1–19.
Black S, Collier E, Davey R, Roberts R. Structure, solubility, screening, and synthesis of molecular salts. J Pharm Sci. 2007;96:1053–68.
Bowker M. A procedure for salt selection and optimization. In: Stahl PH, Wermuth CG, editors. Handbook of pharmaceutical salts: properties, selection and use. Weinheim: Wiley-VCH; 2002. p. 161–89.
Davies G. Changing the salt, changing the drug. Pharm J. 2001;266:322–3.
Gould P. Salt selection for basic drugs. Int J Pharm. 1986;33:201–17.
Serajuddin A. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59:603–16.
Albini A, Fasani E. Photochemistry of drugs: An overview and practical problems. In: Albini A, Fasani E, editors. Drugs: photochemistry and photostability. Cambridge: Royal Society of Chemistry; 1998. p. 1–65.
Aman W, Thoma K. The influence of formulation and manufacturing process on the photostability of tablets. Int J Pharm. 2002;243:33–41.
Tonnesen H. Formulation and stability testing of photolabile drugs. Int J Pharm. 2001;225:1–14.
Albini A, Fasani E. Photochemistry of drugs: an overview and practical problems. Spec Publ R Soc Chem. 1998;225:1–73.
Moan J. Benefits and adverse effects from the combination of drugs and light. In: Tonnesen HH, editor. The photostability of drugs and drug formulations. London: Taylor and Francis; 1996. p. 173–88.
Woo J, Chi M, Kim Y, Yi H. Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation therof, Patent No US 2009/0005425 A1 2006.
Nord K, Orsteen A, Karlsen J, Tonnesen H. Pharmazie. 1997;52:8.
Torniainen K, Tammilehto S, Ulvi V. The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin. Int J Pharm. 1996;132:53–61.
Minipress package insert, http://wwwpfizercom/files/products/uspi_minipresspdf.
Prazosin hydrochloride—monograph, United States Pharmacopeia, USP29NF24.
Bianco E. Novel crystalline forms of prazosin hydrochloride, Patent No 4092315 1978.
Thoma K. Photodecomposition and stabilization of compounds in dosage forms. In: Tonnesen HH, editor. The photostability of drugs and drug formulations. London: Taylor and Francis; 1996. p. 111–40.
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Q1B: Stability testing: photostability testing of new drug substances and products; 1996.
Serajuddin A, Jarowski C. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts II: salicylic acid, theophylline, and benzoic acid. J Pharm Sci. 1985;74:148–54.
Serajuddin A, Jarowski C. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts I: phenazopyridine. J Pharm Sci. 1985;74:142–7.
Serajuddin A, Thakur A, Ghoshal R, Fakes M, Ranadive S, Morris K, et al. Selection of solid dosage form composition through drug–excipient compatibility testing. J Pharm Sci. 1999;88:696–704.
Budrugeac P, Segal E. Applicability of the Kissinger equation in thermal analysis. J Therm Anal Calorim. 2007;88:703–7.
Kissinger H. Reaction kinetics in differential thermal analysis. Anal Chem. 1957;29:1702–6.
Kumar L, Meena C, Pawar Y, Wahlang B, Jain R, Bansal A. Effect of counterion on the physicochemical properties of prazosin salts. AAPS Pharm Sci Tech. 2013;14:141–50.
Kumar L, Bansal A. Effect of humidity on the hydration behaviour of prazosin hydrochloride polyhydrate: thermal, sorption and crystallographic study. Thermochim Acta. 2011;525:206–10.
Carstensen J. Stability of solids and solid dosage forms. J Pharm Sci. 1974;63:1–14.
Dotterer R, Allen J. Finding peacable photostability. Pharm Formul Qual. 2006.
Doigan P, Davis T. The photolysis of crystalline nitrates. J Phys Chem. 1952;56:764–6.
Akimoto K, Inoue K, Sugimoto I. Photostability of several crystal forms of cianidanol. Chem Pharm Bull. 1985;33:4050–3.
Akimoto K, Nakagawa H, Sugimoto I. Photostability of cianidanol in aqueous solution. Drug Dev Ind Pharm. 1985;11:865–89.
Sheng J, Venkatesh G, Duddu S, Grant D. Dehydration behavior of eprosartan mesylate dihydrate. J Pharm Sci. 1999;88:1021–9.
Ross D, Riley C. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm. 1990;63:237–50.
Tonnesen H, Kristensen S, Nord K. Photoreactivity of selected antimalarial compounds in solution and in the solid state. In: Albini A, Fasani E, editors. Drugs: photochemistry and photostability. Cambridge: Royal Society of Chemistry; 1998. p. 87–115.
Badawy S, Hussain M. Microenvironmental pH modulation in solid dosage forms. J Pharm Sci. 2007;96:948–59.
Torniainen K, Mattinen J, Askolin C, Tammilehto S. Structure elucidation of a photodegradation product of ciprofloxacin. J Pharm Biomed Anal. 1997;15:887–94.
Albini A, Fasani E. Rationalizing the photochemistry of drugs. In: Tonnesen HH, editor. Photostability of drugs and drug formulations. New York: CRC; 2004. p. 67–110.
HPV assessment report on para toluenesulfonic acid http://wwwepagov/hpv/pubs/summaries/ptolacid/c16597rspdf Accessed 05 August 2011.
Oxalic acid—material safety data sheet http://wwwchemcasorg/drug/analytical/cas/6153-56-6asp Accessed 05 August 2011.
ACKNOWLEDGMENTS
Lokesh Kumar acknowledges the Department of Science and Technology, Government of India, and Ranbaxy Science Foundation for providing research fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, L., Jog, R., Singh, S. et al. Effect of Counterion on the Solid State Photodegradation Behavior of Prazosin Salts. AAPS PharmSciTech 14, 757–763 (2013). https://doi.org/10.1208/s12249-013-9961-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-013-9961-1